Partner
Natalie McNamee
Director, Tarnagulla Ventures
- Firm
- Tarnagulla Ventures
- Title
- Director
- Role
- Executive
Record updated 18 September 2026
About
Natalie has been a Director of Tarnagulla Ventures Pty Ltd since 2015. She had led the investment diligence into most of the portfolio companies since then, including Lubris BioPharma, a company which has since successfully licensed their lead indication to Novartis. Prior to returning to Australia, Natalie worked for Tocagen Inc, a gene therapy company, based in San Diego, in their business development team whilst finishing her Masters. She then worked as a bioengineer at the then-newly formed Quanticel Pharmaceuticals, a cancer stem cell focused drug developer. Quanticel was acquired by Celgene for $485M in 2015. Natalie received her Masters in Bioengineering at UC San Diego and a dual Bachelor of Finance and Mechanical Engineering from Melbourne University.
Background
- Education
- Natalie received her Masters in Bioengineering at UC San Diego and a dual Bachelor of Finance and Mechanical Engineering from Melbourne University.Source (opens in a new tab)
Is this you? Remove my profile